Antistaphylococcal penicillins
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Penicillin resistance in Staphylococcus aureus appeared very soon after penicillin entered general clinical use in 1943, and the mechanism of resistance was the production of β-lactamase. Modifications of the penicillin molecule so that it was resistant to being broken down by β-lactamase was able to temporarily overcome this problems: these compounds became known as antistaphylococcal penicillins. The first of these compounds was methicillin, which is no longer in general use. The range of these penicillins available in each country is very different, and the reasons for this are historical.
- Cloxacillin (US)
- Flucloxacillin (UK and Australia)
- Methicillin
- Nafcillin (US)
- Oxacillin